The contribution of glycemic control to impaired growth during puberty in young people with type 1 diabetes and microalbuminuria-Reference-Cited by-同舟云学术

The contribution of glycemic control to impaired growth during puberty in young people with type 1 diabetes and microalbuminuria

Published:2013-12-09 Issue:4 Volume:15 Page:303-308
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:Pediatr Diabetes

Author:

Marcovecchio M Loredana¹²,Heywood James JN¹,Dalton R Neil³,Dunger David B¹

Affiliation:

1. Department of Paediatrics, MRL Wellcome Trust-MRC Institute of Metabolic Science, NIHR Cambridge Comprehensive Biomedical Research Centre; University of Cambridge; Cambridge CB2 0QQ UK

2. Department of Paediatrics; University of Chieti; Chieti 66100 Italy

3. WellChild Laboratory, Evelina Children's Hospital; King's College London; London SE1 7EH UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pedi.12090/fullpdf

Reference28 articles.

1. Short stature and the risk of adiposity, insulin resistance, and type 2 diabetes in middle age: the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994;Asao;Diabetes Care,2006

2. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis;Paajanen;Eur Heart J,2010

3. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial;Waden;Diabetes,2009

4. Short stature and diabetic nephropathy;Chaturvedi;BMJ,1995

5. Short stature and diabetic nephropathy;Rossing;BMJ,1995

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-like growth factor 1 and sex hormones for assessment of anthropometric and pubertal growth of Egyptian children and adolescents with type 1 diabetes mellitus (single center study);BMC Endocrine Disorders;2024-05-09

2. Implication of Pappalysins and Stanniocalcins in the Bioavailability of IGF-I in Children With Type 1 Diabetes Mellitus;Journal of the Endocrine Society;2024-04-06

3. Puberty in boys with type 1 diabetes mellitus: What has changed?;Diabetes Research and Clinical Practice;2023-09

4. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes;Pediatric Diabetes;2022-12

5. Three‐variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes;Pediatric Diabetes;2022-02-04